Reproductive Medicine and Immunology, Obstetrics and Gynaecology, Clinical Sciences Department, Chicago Medical School, Rosalind Franklin University of Medicine and Science, Vernon Hills, IL 60061, USA; IVF and Reproductive Endocrinology Department, Women's Health Hospital, King Abdulaziz Medical City, Riyadh, Saudi Arabia.
Reproductive Medicine and Immunology, Obstetrics and Gynaecology, Clinical Sciences Department, Chicago Medical School, Rosalind Franklin University of Medicine and Science, Vernon Hills, IL 60061, USA; Department of Reproductive Medicine, Jiangsu Province Hospital, Guangzhou Road 300, Nanjing, Jiangsu 210029, China.
J Reprod Immunol. 2024 Sep;165:104295. doi: 10.1016/j.jri.2024.104295. Epub 2024 Jul 11.
During pregnancy, a unique immune milieu is established systemically and locally at the maternal-fetal interface. While preparing for embryonic implantation, endometrial effectors significantly change their proportions and function, which are synchronized with hormonal changes. During assisted reproductive technology cycles, various cytokines, chemokines, and immune factors dynamically change with the altered receptor expressions on the immune effectors. Thus, the hormonal regulation of immune effectors is critical to maintaining the immune milieu. In this review, hormonal effects on T cell subsets are reviewed. Sex hormones affect T cell ontogeny and development, consequently affecting their functions. Like other T cell subsets, CD4+ T helper (Th) cells are modulated by estrogen, where low estrogen concentration promotes Th1-driven cell-mediated immunity in the uterus and in vitro by enhancing IFN-γ production, while a high estrogen level decreases it. The abundance and differentiation of T regulatory (Treg) cells are controlled by estrogen, inducing Treg expansion. Conversely, progesterone maintains immune homeostasis by balancing Th1/Th2 and Th17/Treg immunity, leading to maternal-fetal tolerance. Therefore, the understanding of the hormonal impact on various T cell subsets during the reproductive cycles is critical to improving reproductive outcomes in women with recurrent pregnancy losses, repeated implantation failures, and undergoing assisted reproductive cycles.
在怀孕期间,母体-胎儿界面会在全身和局部建立独特的免疫微环境。在为胚胎着床做准备时,子宫内膜效应物的比例和功能会发生显著变化,与激素变化同步。在辅助生殖技术周期中,各种细胞因子、趋化因子和免疫因子会随着免疫效应物上受体表达的改变而动态变化。因此,免疫效应物的激素调节对维持免疫微环境至关重要。本综述讨论了激素对 T 细胞亚群的影响。性激素影响 T 细胞的发生和发育,进而影响其功能。与其他 T 细胞亚群一样,雌激素会调节 CD4+辅助性 T 细胞(Th),其中低浓度的雌激素通过增强 IFN-γ 的产生促进子宫内和体外的 Th1 细胞介导的免疫,而高浓度的雌激素则会降低其功能。雌激素控制 T 调节(Treg)细胞的丰度和分化,诱导 Treg 细胞扩增。相反,孕激素通过平衡 Th1/Th2 和 Th17/Treg 免疫来维持免疫平衡,导致母体-胎儿耐受。因此,了解生殖周期中各种 T 细胞亚群的激素影响对于改善复发性妊娠丢失、反复着床失败和接受辅助生殖周期的女性的生殖结局至关重要。
J Reprod Immunol. 2024-9
Syst Biol Reprod Med. 2017-12
J Reprod Immunol. 2012-2-25
Int J Mol Sci. 2025-7-6
J Fungi (Basel). 2025-4-20
Cells. 2025-1-6